2021 Form 10-K Financial Statement

#000121390022011342 Filed on March 09, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q3
Revenue $0.00
YoY Change
Cost Of Revenue $6.585M
YoY Change 12.31%
Gross Profit $14.61M
YoY Change 104.25%
Gross Profit Margin
Selling, General & Admin $20.76M
YoY Change 9.97%
% of Gross Profit 142.08%
Research & Development $59.18M
YoY Change 9.03%
% of Gross Profit 405.0%
Depreciation & Amortization $5.502M $4.547M
YoY Change -8.86%
% of Gross Profit 37.65%
Operating Expenses $1.015M
YoY Change 140908.33%
Operating Profit $13.60M
YoY Change 90.08%
Interest Expense $33.37K
YoY Change -100.85%
% of Operating Profit 0.25%
Other Income/Expense, Net -$502.0K
YoY Change -3052.94%
Pretax Income -$981.9K
YoY Change 136272.22%
Income Tax
% Of Pretax Income
Net Earnings -$981.9K
YoY Change 136272.22%
Net Earnings / Revenue
Basic Earnings Per Share -$1.18
Diluted Earnings Per Share -$56.23K
COMMON SHARES
Basic Shares Outstanding 67.26M shares
Diluted Shares Outstanding 67.26M shares

Balance Sheet

Concept 2021 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $235.3K
YoY Change -99.46%
Cash & Equivalents $235.3K
Short-Term Investments
Other Short-Term Assets $98.07K
YoY Change
Inventory
Prepaid Expenses
Receivables $2.060M
Other Receivables $0.00
Total Short-Term Assets $333.4K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $16.45M
YoY Change 57.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $133.0M
YoY Change
Other Assets $5.286M
YoY Change 24.29%
Total Long-Term Assets $133.0M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $333.4K
Total Long-Term Assets $133.0M
Total Assets $133.3M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.760M
YoY Change 12.71%
Accrued Expenses $247.9K
YoY Change -92.73%
Deferred Revenue
YoY Change
Short-Term Debt $1.820K
YoY Change 152.78%
Long-Term Debt Due $61.13M
YoY Change 2522.61%
Total Short-Term Liabilities $497.2K
YoY Change 68955.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $247.5K
YoY Change -99.1%
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $497.2K
Total Long-Term Liabilities $0.00
Total Liabilities $497.2K
YoY Change 68955.56%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $132.8M
YoY Change
Total Liabilities & Shareholders Equity $133.3M
YoY Change

Cashflow Statement

Concept 2021 2020 Q3
OPERATING ACTIVITIES
Net Income -$981.9K
YoY Change 136272.22%
Depreciation, Depletion And Amortization $5.502M $4.547M
YoY Change -8.86%
Cash From Operating Activities -$864.4K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$636.0K $1.655M
YoY Change -70.58%
Acquisitions
YoY Change
Other Investing Activities -$133.0M $12.59M
YoY Change -1077.22%
Cash From Investing Activities -$133.0M
YoY Change -1261.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 134.1M
YoY Change 150.87%
NET CHANGE
Cash From Operating Activities -864.4K
Cash From Investing Activities -133.0M
Cash From Financing Activities 134.1M
Net Change In Cash 235.3K $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$864.4K
Capital Expenditures -$636.0K $1.655M
Free Cash Flow -$228.4K -$1.655M
YoY Change -110.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
atspu Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
USD
atspu Deferred Offering Costs Included In Accrued Offering Costs And Expenses
DeferredOfferingCostsIncludedInAccruedOfferingCostsAndExpenses
USD
atspu Subsequent Measurement Of Common Stock Subject To Redemption
SubsequentMeasurementOfCommonStockSubjectToRedemption
USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
USD
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
USD
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001840856
us-gaap Interest Income Other
InterestIncomeOther
USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
shares
atspu Basic And Diluted Net Loss Per Sharein Dollars Per Share
BasicAndDilutedNetLossPerShareinDollarsPerShare
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
USD
atspu Payment Of Underwriting Fees
PaymentOfUnderwritingFees
USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
atspu Subsequent Measurement Of Common Stock Subject To Redemptioninterest Earned On Trust Acco
SubsequentMeasurementOfCommonStockSubjectToRedemptioninterestEarnedOnTrustAcco
USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
atspu Initial Classification Of Warrant Liability
InitialClassificationOfWarrantLiability
USD
CY2020Q4 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
USD

Files In Submission

Name View Source Status
0001213900-22-011342-index-headers.html Edgar Link pending
0001213900-22-011342-index.html Edgar Link pending
0001213900-22-011342.txt Edgar Link pending
0001213900-22-011342-xbrl.zip Edgar Link pending
atspu-20211231.xsd Edgar Link pending
atspu-20211231_cal.xml Edgar Link unprocessable
atspu-20211231_def.xml Edgar Link unprocessable
atspu-20211231_lab.xml Edgar Link unprocessable
atspu-20211231_pre.xml Edgar Link unprocessable
f10k2021ex21-1_archimedes.htm Edgar Link pending
f10k2021ex31-1_archimedes.htm Edgar Link pending
f10k2021ex31-2_archimedes.htm Edgar Link pending
f10k2021ex32-1_archimedes.htm Edgar Link pending
f10k2021ex32-2_archimedes.htm Edgar Link pending
f10k2021ex4-6_archimedes.htm Edgar Link pending
f10k2021_archimedestech.htm Edgar Link pending
f10k2021_archimedestech_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending